Novo Nordisk A/S Stock Performance
as on June 8, 2026 at 2:16 pm IST
Day's Low
Day's High
$42.86$44.22
0.23%
Downside
2.93%
Upside
52 Week's Low
52 Week's High
$35.12$81.4418.25%
Downside
89.57%
Upside
Novo Nordisk A/S share price movements today
- Previous Close
- $43.75
- Open
- $44.05
- Volume
- 10.1M
- Day's Low - High
- $42.86 - $44.22
- 52 Week Low - High
- $35.12 - $81.44
Novo Nordisk A/S Historical Returns
- 1 Month Return
- -6.75 %
- 3 Month Return
- + 11.35 %
- 1 Year Return
- -42.44 %
- 3 Year Return
- -46.11 %
- 5 Year Return
- + 4.42 %
Novo Nordisk A/S Stock Fundamentals & Key Indicators
Check Novo Nordisk A/S market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$190.3B
EPS (TTM)
22.3207
Dividend Yield
4.19%
Quarterly Earnings Growth YOY
0.67%
PE Ratio (TTM)
10.08
Industry PE ratio
11.438461538461539
PEG Ratio
3.1699
EBITDA
173.9B
Revenue (TTM)
327.8B
Profit Margin
37.21%
Return On Equity TTM
71.40%
Novo Nordisk A/S Stock Valuation
Track how Novo Nordisk A/S P/E has moved over time to understand its valuation trends.
Novo Nordisk A/S in the last 5 years
Lowest (2.05x)
March 31, 2026
Today (10.08x)
June 8, 2026
Industry (11.44x)
June 8, 2026
Highest (45.23x)
June 30, 2024
Today’s Price to Earnings Ratio: 10.08x
Novo Nordisk A/S vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Novo Nordisk A/S with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $190.3B | 4.42% | 10.08 | 37.21% | 4.19% | |
| BUY | $1.0T | 412.65% | 40.16 | 34.99% | 0.5499999999999999% | |
| BUY | $288.4B | 230.23% | 28 | 17.19% | 1.76% | |
| BUY | $401.5B | 102.27% | 110.84 | 5.79% | 3% | |
| BUY | $560.3B | 42.46% | 26.94 | 21.83% | 2.2800000000000002% |
Stock Returns calculator for Novo Nordisk A/S Stock including INR - Dollar returns
The Novo Nordisk A/S stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Novo Nordisk A/S investment value today
Current value as on today
₹63,799
Returns
Returns from Novo Nordisk A/S Stock
Dollar Impact
₹6,235 (+6.24%)
Analyst Recommendation on Novo Nordisk A/S Stock
Based on 32 analysts
62.50%
Buy
31.25%
Hold
6.25%
Sell
Based on 32 analysts, 62.5% of analysts recommend a 'BUY' rating for Novo Nordisk A/S. Average target price of $46.9
Novo Nordisk A/S Share Price Target
Get share price movements and forecasts by analysts on Novo Nordisk A/S.
What analysts predicted
8.4%UPSIDE
Target Price
$46.9
Current Price
$42.96
Analyzed by
32 Analysts
Target
$46.90
Novo Nordisk A/S target price $46.9, a slight upside of 8.4% compared to current price of $42.96. According to 32 analysts rating.
Indian Investors' Interest in Novo Nordisk A/S Stock
Investment in Novo Nordisk A/S Shares on INDmoney has dropped by -25.08% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Novo Nordisk A/S Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:40% versus previous 30 day period
Novo Nordisk A/S Quarterly Profit & Loss
All numbers in Millions USD
Novo Nordisk A/S Annual Profit & Loss
All numbers in Millions USD
Novo Nordisk A/S Quarterly Cash Flow
All numbers in Millions USD
Novo Nordisk A/S Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Novo Nordisk A/S Stock
Check out the Mutual Funds with significant holdings in Novo Nordisk A/S.
Funds | Holdings | Shares Held |
|---|---|---|
 DSP Value Fund Direct Plan Growth | 0.73105% | 30961 |
DSP Multi Asset Allocation Fund Direct Growth | 0.55081% | 126584 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 1.03021% | 4396 |
Global Institutional Holdings in Novo Nordisk A/S
Novo Nordisk A/S News & Key Events
Today's Timeline - 27 May
Wed, 08:02 PM
-Despite positive Q1 guidance, Novo Nordisk faces competition and pricing pressures, expecting sales decline in 2026.
Thu, 01:50 AM
-Novo Nordisk's oral Wegovy approved in the EU, expanding its market presence against competitors.
Thu, 03:09 AM
-Novo Nordisk raises full-year outlook after strong Q1 results driven by Wegovy sales, exceeding analyst expectations.
Insights on Novo Nordisk A/S
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Novo-Nordisk A/S has shown strong revenue performance over the last three quarters. The revenue increased from $74.97 billion to $96.82 billion. This reflects an average quarterly growth rate of 11.8%, indicating a positive trend in the company's financial performance.
- POSITIVE IMPACT
Profit Spike
Novo-Nordisk A/S has shown strong profit growth over the last three quarters. Their net profit increased from $20.00 billion to $48.55 billion, reflecting an average growth rate of 35.1% per quarter.
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly & Co. has given 150.4% return, outperforming this stock by 196.5%
- NO EFFECT
Against Peers
In the last 1 year, AstraZeneca PLC has given 155.1% return, outperforming this stock by 197.5%
NEGATIVE IMPACTPrice Dip
In the last 1 year, NVO stock has moved down by -42.4%
About Novo Nordisk A/S
| Organisation | Novo Nordisk A/S |
| Headquarters | Novo Alle 1, Bagsvaerd, Denmark, 2880 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Maziar Mike Doustdar B.A. |
| E-voting on shares | Click here to vote |
Key Management of Novo Nordisk A/S
Name | Title |
|---|---|
Ms. Tania Sabroe | EVP of People, Organisation and Corporate Affairs & Member of Management Board |
Mr. John F. Kuckelman | SVP, Group General Counsel, Global Legal, IP & Security and Member of Management Board |
Mr. Emil Kongshoej Larsen | EVP of International Operations & Member of Management Board |
Ms. Elin Jager | SVP, Chief of Staff to CEO, Corporate Strategy & Sustainability and Member of Management Board |
Ms. Hong Chow | Executive VP of Product & Portfolio Strategy and Member of Management Board |
Mr. Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board |
Dr. Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board |
Ms. Thilde Hummel Bogebjerg | Executive VP of Enterprise IT & Quality and Member of Management Board |
Mr. Jamey Millar | Executive VP of US Operations & Member of Management Board |
Mr. Maziar Mike Doustdar B.A. | President, CEO & Member of the Management Board |
FAQs
What is Novo Nordisk A/S share price today?
Novo Nordisk A/S share price today is $42.96 as on at the close of the market. Novo Nordisk A/S share today touched a day high of $44.22 and a low of $42.86.
What is the 52 week high and 52 week low for Novo Nordisk A/S share?
Novo Nordisk A/S share touched a 52 week high of $81.44 on and a 52 week low of $35.12 on . Novo Nordisk A/S stock price today i.e. is closed at $42.96,which is 47.25% down from its 52 week high and 22.32% up from its 52 week low.
What is Novo Nordisk A/S's market capitalisation today?
Novo Nordisk A/S market capitalisation is $0.19T as on .
How to invest in Novo Nordisk A/S Stock (NVO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Novo Nordisk A/S on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novo Nordisk A/S Shares that will get you 0.0349 shares as per Novo Nordisk A/S share price of $42.96 per share as on June 8, 2026 at 8:46 am IST.
What is the minimum amount required to buy Novo Nordisk A/S Stock (NVO) from India?
Indian investors can start investing in Novo Nordisk A/S (NVO) shares with as little as ₹94.95 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Novo Nordisk A/S stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novo Nordisk A/S share’s latest price of $42.96 as on June 8, 2026 at 8:46 am IST, you will get 0.2328 shares of Novo Nordisk A/S. Learn more about
fractional shares .
What are the returns that Novo Nordisk A/S has given to Indian investors in the last 5 years?
Novo Nordisk A/S stock has given 4.42% share price returns and 31.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?